Journal of pharmacological and toxicological methods最新文献

Corrigendum to "Nonclinical cardiovascular safety assessment of thioridazine: Impact of heart rate, body temperature, and choice of species" [Journal of Pharmacological and Toxicological Methods, Volume 115 (2022), 107167]. “硫胺嘧啶非临床心血管安全性评估：心率、体温和物种选择的影响”的更正[Journal of pharmacology and Toxicological Methods， vol . 115(2022), 107167]。

Journal of pharmacological and toxicological methods Pub Date : 2026-08-01 Epub Date: 2026-06-23 DOI: 10.1016/j.vascn.2026.108559

Andrea Greiter-Wilke, Sonia Roberts, Katja Heinig, David Waiz, Roland Jenni, Henry Holzgrefe

引用次数: 0

WITHDRAWN: Simultaneous quantification of venetoclax, busulfan and voriconazole in plasma by LC-MS/MS: clinical applications in patients with acute myeloid leukemia LC-MS/MS同时测定急性髓系白血病患者血浆中venetoclax、busulfan和voriconazole含量的临床应用

Journal of pharmacological and toxicological methods Pub Date : 2026-03-05 DOI: 10.1016/j.vascn.2026.108419

Zhenhua Zhang, Bingchen Ge, Yanyu Wang, Changrui Long, Huixing Wu, Hui Chen, Shijian Xiang, Benjie Zhou

引用次数: 0

Therapeutic drug monitoring of busulfan and cyclophosphamide in hematologic malignancies: An LC-MS/MS development, validation and application. 丁硫凡和环磷酰胺在血液恶性肿瘤中的治疗药物监测：LC-MS/MS开发、验证和应用。

Journal of pharmacological and toxicological methods Pub Date : 2025-09-01 Epub Date: 2025-08-05 DOI: 10.1016/j.vascn.2025.108389

Jinxingyi Wang, Ruyu Tao, Hanshuai Hu, Xue Lan, Jiejie Gao, Yanping Guan, Qian Liu

{"title":"Therapeutic drug monitoring of busulfan and cyclophosphamide in hematologic malignancies: An LC-MS/MS development, validation and application.","authors":"Jinxingyi Wang, Ruyu Tao, Hanshuai Hu, Xue Lan, Jiejie Gao, Yanping Guan, Qian Liu","doi":"10.1016/j.vascn.2025.108389","DOIUrl":"10.1016/j.vascn.2025.108389","url":null,"abstract":"Background: Busulfan and cyclophosphamide (Bu-Cy) is a widely used conditioning regimen for hematopoietic stem cell transplantation (HSCT) in the treatment of hematologic malignancies. To explore the exposure-efficiency relationships of Bu-Cy regimen and evaluate the necessity of relative therapeutic drug monitoring (TDM), we developed a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method to simultaneously quantify the busulfan and cyclophosphamide in human plasma.Methods: A simple LC-MS/MS bioassay for simultaneous determination of busulfan and cyclophosphamide using isotope dilution internal standardization has been established. Plasma samples were subjected to protein precipitation prior to their injection into a column for subsequent separation (Thermo Accucore aQ C18, 50 × 2.1 mm, 2.6 μm). Positive electrospray ionization (ESI) mode with selected reaction monitoring (SRM) was used for analytes determination.Results: Busulfan and cyclophosphamide could be measured within 3 min, with the calibration ranges of 80-4000 ng/mL for busulfan and 25-2000 ng/mL for cyclophosphamide. The validated method showed good sensitivity and linearity. Accuracies and precisions were less than 15 %. The results of stability showed that busulfan and cyclophosphamide were stable in the plasma under room temperature for 16 h, 4 °C for 24 h, -80 °C for 2 weeks, and after three freeze-thaw processes.Conclusion: The bioassay was simple, sensitive and successfully implemented in the realm of TDM for Bu-Cy, ultimately leading to improved dosing precision.","PeriodicalId":94102,"journal":{"name":"Journal of pharmacological and toxicological methods","volume":" ","pages":"108389"},"PeriodicalIF":0.0,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144786281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Corrigendum to "Best practice considerations for nonclinical in vivo cardiovascular telemetry studies in non-rodent species: Delivering high quality QTc data to support ICH E14/S7B Q&As" [J. Pharmacol. Toxicol. Methods 123 (2023) 107270]. 《非啮齿类动物非临床体内心血管遥测研究的最佳实践考虑：提供高质量的QTc数据以支持ICH E14/S7B Q&As》的更正[J]。杂志。Toxicol。方法123(2023)107270]。

Journal of pharmacological and toxicological methods Pub Date : 2025-09-01 Epub Date: 2025-09-16 DOI: 10.1016/j.vascn.2025.108392

Eric I Rossman, Todd A Wisialowski, Hugo M Vargas, Jean-Pierre Valentin, Michael G Rolf, Brian M Roche, Steve Riley, Michael K Pugsley, Jill Nicholsi, Dingzhou Li, Derek J Leishman, Robert B Kleiman, Andrea Greiter-Wilke, Gary A Gintant, Michael J Engwall, Annie Delaunois, Simon Authier

引用次数: 0